Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
127.99
+0.49 (+0.38%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,532,402
Open
128.27
Bid (Size)
127.99 (4)
Ask (Size)
128.55 (10)
Prev. Close
127.50
Today's Range
127.09 - 128.73
52wk Range
99.14 - 133.10
Shares Outstanding
2,531,374,696
Dividend Yield
2.28%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Cracking The Code: Understanding Analyst Reviews For Merck & Co
June 18, 2024
Via
Benzinga
Competitor Analysis: Evaluating Merck & Co And Competitors In Pharmaceuticals Industry
June 18, 2024
Via
Benzinga
Performance
YTD
+13.03%
+13.03%
1 Month
-2.29%
-2.29%
3 Month
+3.34%
+3.34%
6 Month
+21.48%
+21.48%
1 Year
+16.11%
+16.11%
More News
Read More
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
June 18, 2024
Via
Benzinga
Exposures
COVID-19
FDA Approves Merck's Pneumococcal Vaccine As First Shot Designed For Adults
June 18, 2024
Via
Benzinga
Exposures
Product Safety
U.S. FDA Approves CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults
June 17, 2024
From
Merck & Co., Inc.
Via
Business Wire
Merck & Co Unusual Options Activity For June 14
June 14, 2024
Via
Benzinga
How Is The Market Feeling About Merck & Co?
June 11, 2024
Via
Benzinga
Market Whales and Their Recent Bets on MRK Options
June 07, 2024
Via
Benzinga
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Carboplatin and Paclitaxel as Treatment for Adult Patients With Primary Advanced or Recurrent Endometrial Carcinoma
June 17, 2024
From
Merck & Co., Inc.
Via
Business Wire
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines
June 17, 2024
Via
MarketBeat
Exposures
COVID-19
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street
June 17, 2024
Via
The Motley Fool
3 Crazy Good Stocks to Buy With $500 Right Now
June 12, 2024
Via
InvestorPlace
Comparative Study: Merck & Co And Industry Competitors In Pharmaceuticals Industry
June 04, 2024
Via
Benzinga
3 Penny Stocks to Buy if You Want to Spend Less and Earn More
June 11, 2024
Via
InvestorPlace
3 High-Yield Dividend Stocks to Collect Impressive Payouts Year After Year
June 11, 2024
Via
InvestorPlace
Healthcare And Biotech Investing: Breakthroughs In The Treatment Of Cancer At ASCO
June 10, 2024
Via
Talk Markets
From $10k to $100k: 3 Stocks With the Potential for Amazing Returns
June 10, 2024
Via
InvestorPlace
Nike, Merck, General Motors, And More: CNBC's 'Final Trades'
June 10, 2024
Via
Benzinga
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
June 10, 2024
Via
Investor's Business Daily
Exposures
COVID-19
Why Moderna Stock Is a No-Brainer Buy Right Now
June 10, 2024
Via
The Motley Fool
3 Reasons to Buy Moderna Stock
June 08, 2024
Via
The Motley Fool
2 Dividend Stocks Billionaires Are Buying: Should You?
June 07, 2024
Via
The Motley Fool
Exit Strategy: 3 Overvalued Stocks to Sell Before They Deflate
June 06, 2024
Via
InvestorPlace
Merck to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024
From
Merck & Co., Inc.
Via
Business Wire
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
June 04, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.